Doxy-PEP: Who, When, and How?

  Рет қаралды 3,206

IAS-USA

IAS-USA

Күн бұрын

Presenter: Annie F. Luetkemeyer, MD
Moderator: Connie L. Celum, MD, MPH
September 26, 2023
Given the increasing burden of gonorrhea, chlamydia, and syphilis infections in the US, effective tools are needed to fight against bacterial sexually transmitted infections (STIs). Doxycycline postexposure prophylaxis (doxy-PEP) is a sexual-health strategy that shows considerable promise in this endeavor. Drug formulations and recommendations for use continue to evolve, particularly for patients with HIV. Presented by Annie Luetkemeyer, MD, and moderated by Connie Celum, MD, this webinar reviews the current recommendations by the Centers for Disease Control and Prevention (CDC) for the use of doxy-PEP. Topics will include the criteria to determine appropriate candidates for doxy-PEP therapy, strategies for effective doxy-PEP administration, and questions that remain to be answered in future studies on doxy-PEP in patients with HIV.

Пікірлер
STI Expert Hour Webinar - doxyPEP: Promise, Opportunities, and Considerations for Implementation
1:14:34
California Prevention Training Center (CAPTC)
Рет қаралды 1,4 М.
Они убрались очень быстро!
00:40
Аришнев
Рет қаралды 3,1 МЛН
693 - DoxyPEP: A “Morning-After Pill” for STIs
15:39
Public Health on Call
Рет қаралды 422
What to expect when beginning treatment for HIV/AIDS, explained by an expert | Stanford
7:09
Stanford Center for Health Education
Рет қаралды 116 М.
Can Julie Bowen Identify Her Kids By Feeling Their Faces?
4:53
Jimmy Kimmel Live
Рет қаралды 12 МЛН
Doxycycline
21:16
wellnowdoctor
Рет қаралды 41 М.
Matthew Perry's Death From Ketamine Explained (Is It Safe For You?)
18:40